|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,945.84 |
3.29% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$65,226.60 |
3.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$54,966.78 |
2.58% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$53,487.41 |
2.51% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$52,761.96 |
2.48% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$48,731.07 |
2.29% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$47,995.06 |
2.26% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,574.48 |
2.24% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,392.07 |
2.23% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,077.20 |
2.21% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$46,296.97 |
2.18% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,615.15 |
2.14% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,092.74 |
2.12% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,830.74 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,810.14 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,620.47 |
2.10% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$44,590.32 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,204.45 |
2.08% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$44,077.65 |
2.07% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,858.88 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,597.16 |
2.05% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,183.06 |
2.03% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,639.24 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,167.84 |
1.98% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$41,489.51 |
1.95% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,238.30 |
1.94% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$41,107.57 |
1.93% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$40,756.67 |
1.92% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$40,578.29 |
1.91% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$39,740.38 |
1.87% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$39,523.85 |
1.86% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$39,434.60 |
1.85% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,042.96 |
1.84% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,025.69 |
1.83% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$38,669.18 |
1.82% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,699.36 |
1.82% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,331.93 |
1.80% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,821.08 |
1.78% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$37,317.00 |
1.75% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,099.86 |
1.74% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,778.26 |
1.73% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,458.60 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$36,049.28 |
1.69% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$35,972.32 |
1.69% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$34,493.20 |
1.62% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,535.60 |
1.62% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$34,089.48 |
1.60% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,467.42 |
1.53% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$32,333.42 |
1.52% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$26,989.40 |
1.27% |
| US Dollar |
$USD |
|
2,704 |
$2,704.37 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|